In 1905, Zirm performed the first successful human corneal transplant. One hundred years later, corneal transplantation (penetrating keratoplasty) is a well-established and successful treatment modality for a range of corneal diseases. In the United States, it is estimated that approximately 50,000 surgeries are performed each year, whereas in Sweden, with a population of 9 million, 500 to 600 corneal transplants are performed annually, according to the Swedish Corneal Register.
1 Although most corneal transplants are successful, an overall 2-year rejection rate of 15% in Sweden has been reported,
1 and in so-called high-risk cases, the rejection rate can be much higher.
2 These events underscore the need for a more complete understanding of the pathogenesis of immune rejection after keratoplasty in the normally avascular, transparent, immune-privileged cornea. Of particular interest in this regard are the interactions between the recipient cornea and the new graft at the cellular level where healing, antigen activity, and the ultimate transparency of the cornea are mediated. Unfortunately, these cellular interactions are not well understood. Even the basic question as to whether donor cells survive after transplantation is a fundamental biological problem that to this day remains unanswered. In fact, this important question has been the source of scientific discussion and debate ever since Zirm first showed that penetrating keratoplasty could be performed in humans. An excellent review of the literature relevant to this question was presented by Dohlman
3 and later by Wollensak and Green.
4 Depending on the technique used for analysis, some investigators have concluded that transplanted cells are replaced by cells from the recipient cornea, whereas others have claimed that donor cells in the transplanted tissue survive indefinitely. Without a sensitive and specific technique that could separate and unequivocally identify donor and host cells, both viewpoints could be argued. In a 1999 study by Wollensak and Green,
4 the technique of fluorescent in situ hybridization (FISH) analysis of the X and Y chromosomes was used for the first time to distinguish between individual recipient and donor cells in the human corneal epithelium, stroma, and endothelium with a high reliability in cases of sex mismatch between donor and recipient. In 14 failed, sex-mismatched grafts obtained retrospectively, Wollensak and Green found complete replacement of donor epithelium and endothelium by recipient cells in all grafts, whereas donor keratocytes were found in only three grafts, with a maximum survival time of 4.5 years. They concluded that “all cell types of corneal transplants tend to be replaced by recipient cells in the long term,” although “individual variability in the process of replacement exists.” Moreover, they proposed further studies investigating donor cell replacement in transparent, clinically successful transplants, as their study was limited to failed grafts.